K-numberK240676
Device nameULTIMUS Series Ultrasound Diagnostic System
ApplicantVinno Technology (Suzhou) Co.,Ltd
Product codeIYN
Device classClass II
Decision dateDec 16, 2024
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ULTIMUS Series is a general-purpose ultrasound diagnostic system consisting of a mobile console with touch panel display and various electronic array transducers. It is intended for use by qualified physicians for imaging, measurement, and analysis of the human body and fluids in hospital or clinic settings, supporting clinical applications including abdominal, obstetric, cardiac, vascular, and pediatric imaging.

Technological characteristics

The ULTIMUS Series operates in multiple imaging modes (B, M, PW Doppler, CW Doppler, Color Doppler, 3D/4D, Harmonic Imaging) and includes various processing functions (Tissue Doppler, Elastography, Strain Imaging, Shear Wave Elastography). It has the same acoustic output specifications as the predicate (Track 3; Ispta.3 ≤ 720 mW/cm², MI ≤ 1.9, TI ≤ 6.0) and uses similar probe types (phased array, convex array, linear array, endocavity).

Test standards cited

The device complies with IEC 60601-1:2005 (medical electrical equipment safety), IEC 60601-1-2 Edition 4.1 (electromagnetic disturbances), IEC 60601-2-37 Edition 2.1 (ultrasonic diagnostic equipment), IEC62359 (thermal and mechanical indices), ISO 10993 series (biocompatibility), IEC62304 (software lifecycle), and IEC62366-1 (usability engineering).

Substantial equivalence argument

The ULTIMUS Series and predicate GE LOGIQ E10 share identical intended use, patient population, use environment, indications for use (except ULTIMUS excludes Transesophageal and Intraoperative which do not impact safety), equivalent biocompatible materials, and identical electrical and acoustic safety specifications. Both employ fundamental ultrasonic diagnostic technology with substantially similar imaging modes, functions, and measurement capabilities, and the minor differences in specific operating features do not introduce new safety or effectiveness issues.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →